Human DDX60L knockout A549 cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
DDX60L KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon14 and 4 bp insertion in exon14.
View Alternative Names
DDX6L_HUMAN, DEAD (Asp Glu Ala Asp) box polypeptide 60 like, DEAD box protein 60-like, DKFZp781D1175, FLJ13468, FLJ31033, FLJ39050, Probable ATP-dependent RNA helicase DDX60-like
- Sanger seq
Unknown
Sanger Sequencing - Human DDX60L knockout A549 cell lysate (AB258841)
Allele-1 : 1 bp deletion in exon14
- Sanger seq
Unknown
Sanger Sequencing - Human DDX60L knockout A549 cell lysate (AB258841)
Allele-2 : 4 bp insertion in exon14
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The functions of DDX60L include sensing viral RNA and activating downstream immune responses. It associates with other similar proteins to form a complex that initiates sensing pathways for RNA viruses. This engagement leads to the activation of innate immune responses which are essential for detecting and responding to infections. DDX60L is part of signaling complexes contributing to the regulation and modulation of immune pathways.
Pathways
DDX60L plays a pivotal role in the RIG-I-like receptor (RLR) signaling pathway. This pathway detects viral RNAs and initiates antiviral responses through interferon production. DDX60L interacts with proteins like RIG-I (retinoic acid-inducible gene I) to regulate the type I interferon signaling pathway enhancing the body's ability to fight viral infections. The protein contributes to maintaining cellular homeostasis under immune stress conditions.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 1 US: 1
Adherent/suspension
Adherent
Gender
Male
Complementary Products
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com